Response Pharmaceuticals Alternatives & Competitors
12 companies similar to Response Pharmaceuticals — A Clinical Stage (Phase 2) biopharmaceutical company developing treatments for w...
Companies similar to Response Pharmaceuticals
Verdiva Bio
Transforming lives by accelerating innovation in cardiometabolic health
London, United Kingdom
Lipidio Pharmaceuticals
A Unique Approach to Treating Obesity
San Diego, United States
-Corp.-logo.jpg "SyneuRx International (Taiwan) Corp."){kind=logo}
SyneuRx International (Taiwan) Corp.
Developing new classes of drugs for COVID-19 and multiple major central nervous system dis...
Taiwan
Inventiva Pharma
A clinical-stage biopharmaceutical company focused on the development of oral small molecu...
France
Rival Readout
Competing with Response Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Septerna
Bringing a new era of GPCR medicines to patients with its Native Complex Platform™.
South San Francisco, Unit...
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
OrsoBio
Advancing first-in-class therapies to restore energy homeostasis
Palo Alto, United States
Neurolixis
New treatments for central nervous system disorders
Park Ridge, United States
Bloomsbury Genetic Therapies
Dedicated to delivering the promise of gene therapy
London, United Kingdom
Alaunos Therapeutics
Attacking solid tumors with TCRs
Houston, United States
Cullinan Therapeutics
Science That Moves
Cambridge, United States
About Response Pharmaceuticals
Response Pharmaceuticals is a clinical stage (Phase 2) biopharmaceutical company focused on developing solutions for weight management and metabolic health. Its primary asset, RDX-002, has shown promising results with confirmed efficacy and safety in over 550 subjects. The company is initially targeting a niche opportu...
Clinical Research and Development, Phase 1 and 2 Clinical Trials, Small Molecule Drug Innovation
Healthcare Providers, Patients with Metabolic Disorders, Patients Discontinuing GLP-1 Agonists, Individuals with Antipsychotic-Induced Weight Gain
Clinical Stage Biopharmaceutical, Phase 2 Clinical Development, Weight Management, Metabolic Health, RDX-002, Cardiometabolic Health, Antipsychotic-Induced Weight Gain, Mental Health, AIWG, Drug Efficacy And Safety, Underserved Populations, Psychiatry, Metabolic Dysregulation
B2B, B2C, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Response Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Response Pharmaceuticals on 3 Mar 2026. The 12 companies listed here were last checked between 18 Sep 2025 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
